Health Canada
- Status: approved
umeclidinium 62.5 µg and vilanterol 25 µg (umeclidinium 62.5 µg and vilanterol 25 µg) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
University of Tennessee Graduate School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.